RIZZA, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 3.337
AS - Asia 2.755
EU - Europa 1.935
SA - Sud America 877
AF - Africa 154
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.066
Nazione #
US - Stati Uniti d'America 3.189
SG - Singapore 1.028
BR - Brasile 648
CN - Cina 586
UA - Ucraina 555
VN - Vietnam 518
DE - Germania 446
IT - Italia 183
AT - Austria 182
FR - Francia 158
SE - Svezia 146
IN - India 100
TR - Turchia 85
CA - Canada 83
AR - Argentina 71
KR - Corea 69
FI - Finlandia 63
BD - Bangladesh 58
IQ - Iraq 48
GB - Regno Unito 44
HK - Hong Kong 44
SN - Senegal 43
ZA - Sudafrica 36
CO - Colombia 34
EC - Ecuador 34
ID - Indonesia 32
MX - Messico 31
RU - Federazione Russa 30
PY - Paraguay 24
VE - Venezuela 24
PK - Pakistan 23
PL - Polonia 19
MA - Marocco 18
NL - Olanda 17
PE - Perù 16
SA - Arabia Saudita 16
BE - Belgio 15
PH - Filippine 15
CL - Cile 14
DZ - Algeria 13
AZ - Azerbaigian 12
ES - Italia 12
MY - Malesia 12
JO - Giordania 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
OM - Oman 10
UZ - Uzbekistan 10
EG - Egitto 9
KZ - Kazakistan 9
PA - Panama 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
JP - Giappone 8
KE - Kenya 8
CZ - Repubblica Ceca 7
IR - Iran 7
IE - Irlanda 6
JM - Giamaica 6
LB - Libano 6
PS - Palestinian Territory 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
CR - Costa Rica 5
KG - Kirghizistan 5
ET - Etiopia 4
IL - Israele 4
NG - Nigeria 4
RO - Romania 4
UY - Uruguay 4
AO - Angola 3
BH - Bahrain 3
GE - Georgia 3
HN - Honduras 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
NP - Nepal 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
ME - Montenegro 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BT - Bhutan 1
CY - Cipro 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
Totale 9.056
Città #
Singapore 359
Chandler 357
Jacksonville 337
Dallas 270
San Jose 246
San Mateo 220
Ho Chi Minh City 211
Dearborn 186
Boardman 181
Ashburn 171
Beijing 165
Vienna 122
New York 119
Hanoi 104
Lauterbourg 72
Seoul 69
Izmir 67
Shanghai 67
Lawrence 63
Roxbury 63
São Paulo 59
Grafing 57
Ottawa 54
Munich 52
Rende 46
Des Moines 45
Helsinki 44
Dakar 43
Hong Kong 43
Hefei 37
Los Angeles 37
Bremen 36
Inglewood 35
Haiphong 31
Ann Arbor 29
Wilmington 29
Brooklyn 28
Cambridge 23
Da Nang 23
Guangzhou 23
Turku 19
Council Bluffs 18
Rio de Janeiro 18
Baghdad 17
Johannesburg 17
Pune 16
Brussels 15
Orem 15
Seattle 15
Toronto 15
Cape Town 14
Santa Clara 14
Warsaw 14
Düsseldorf 13
Hanover 13
Ogden 13
The Dalles 13
Baku 12
Curitiba 12
Dhaka 12
Quito 12
San Francisco 12
Asunción 11
Belo Horizonte 11
Columbus 11
Florence 11
Lima 11
Redwood City 11
Amman 10
Cosenza 10
Falls Church 10
London 10
Tashkent 10
Amsterdam 9
Biên Hòa 9
Campinas 9
Caracas 9
Catanzaro 9
Guayaquil 9
Hải Dương 9
Milan 9
Nanjing 9
Tianjin 9
Buenos Aires 8
Chennai 8
Frankfurt am Main 8
Goiânia 8
Lahore 8
Medellín 8
Montreal 8
Porto Alegre 8
Augusta 7
Boston 7
Brasília 7
Guarulhos 7
Hillsboro 7
Houston 7
Moscow 7
Nairobi 7
Riyadh 7
Totale 4.875
Nome #
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 241
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 229
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 221
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 206
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 203
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 200
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 196
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 185
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 185
A new role of leptin as amplifier of estrogen signaling in breast cancer. 183
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 180
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 179
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 176
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 174
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 157
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 156
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 152
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 151
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 149
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 148
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 147
Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells 142
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 140
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 140
Effetti del TGF-β e del Bergaptene in line cellular di tumore mammario umano ERα(+) ed ERα(-) 137
Mammary Epithelium-Specific Conditional Expression of Human Mutant Ki-Ras in Mice Generates Estrogen Receptor Alpha (ER)-Positive Mammary Adenocarcinomas 131
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 131
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 128
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 127
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 124
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 123
Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1 114
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 112
Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line 109
Evidence that estradiol, through a short non genomic loop, downregulates PTB1B and enhances aromatase activity in MCF7 cells 105
In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer. 104
Evidence that estradiol through non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 103
Rapid estradiol/ER{alpha} signaling enhances aromatase enzymatic activity in breast cancer cells 102
Effetto up-regolatorio dell’estradiolo prodotto in situ sull’espressione di FAS-ligand nella linea cellulare sertoliana TM4 101
“Inhibitory role of Farnesoid X Receptor ligands aromatase expression in Leydig tumor cells” 101
Effetti modulatori dell’estradiolo prodotto in situ sull’espressione di Fas Ligand in una linea cellulare sertoliana:TM4 101
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 100
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 99
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-beta estradiol and aromatase activity in MCF-7 cells 98
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 98
Inhibitory role of Farnesoid X Receptor ligands on aromatase expression in Leydig tumor cells. 96
Evidence that farnesoid X receptor ligand through SF-1 responsive element inhibits aromatase expression in Leydig tumor cells 95
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 95
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 95
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 93
Evidence that PI3K/Akt pathway is involved in the short non genomic autocrine loop between 17beta-estradiol and aromatase activity in breast cancer 91
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 91
OHPg/PR-B Through Beclin1 Mediate Autophagy In Breast Cancer Cells 91
Nuclear compartimentalization of protein involved in cell survival is induced by low doses of paclitaxel: an early event which precedes block of MCF-7 cell cycle progression 89
PPARγ ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 86
PPAR-gamma ligand rosiglitazone counteracts the stimulatory effect of leptin on breast cancer growth 86
PPARγ ligand rosiglitazone counteracts the stimulatory effectsof leptin on breast cancer growth 83
Leptin induces functional activity of ERalpha and stimulates aromatase expression in breast cancer cells: a new potential role on tumor progression 82
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 82
Evidences that Leptin Induces HER2 Expression and Enhances Stem Cells Population in Breast Cancer. 81
Evidence that leptin induces HER2 expression and enhances the stem cell population in breast cancer 80
Farnesoid X receptor ligand down-regulates aromatase expression in Leydig tumor cells 76
PPARgamma ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 75
Leptin induces functional activation of ERalpha and enhances aromatase expression in breast cancer cells 74
First evidence of non-genomic estradiol induced up-regulation of aromatase enzymatic activity in MCF-7 breast cancer cells 73
Leptin induces HER2 expression and enhances stem cells population in breast cancer. 72
Leptin stimulates aromatase expression and induces functional activaty of ERalpha in breast cancer cells: a new potential role on tumor progression. 72
PPAR gama ligand rosiglitazone counteracts the stimmulatory effect of leptin on breast cancer growth 67
Leptin induces functional activation of ERα and enhances aromatase expression in breast cancer cells 62
The pMAPK/pAMPK ratio modulates the effect of adiponectin on breast cancer cell growth 62
Leptin stimulates, via MAPKinase, aromatase P II/1.3 promoter activity in MCF-7 cell line 59
Evidence that estradiol, through a short non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 58
Fas Ligand expression in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction via SP-1 57
Leptin stimulates aromatase expression and induces functional activity of ERα in breast cancer cells: a new potential role on tumor progression 53
Leptin stimulates, via MAPKinase, aromatase PII/I.3 promoter activity in MCF-7 cell line 43
null 40
null 34
null 31
null 30
Fas ligand expression in TM4 cells is up-regulated by estrdiol through Estrogen Receptor α interaction with Sp-1 30
null 29
null 29
null 28
null 27
Totale 9.185
Categoria #
all - tutte 47.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 76 24 64
2021/2022952 14 123 0 49 109 69 9 241 11 5 124 198
2022/2023922 135 110 45 99 128 73 24 94 101 19 70 24
2023/2024585 65 18 31 12 17 173 16 35 42 22 33 121
2024/20251.331 106 180 39 101 51 44 62 85 241 104 117 201
2025/20263.740 474 195 472 362 759 252 435 209 316 266 0 0
Totale 9.185